Marker Therapeutics Announces FDA Clearance of IND for MT-601, its Six-Antigen T Cell Therapy for the Treatment of Pancreatic Cancer
Stock Information for Marker Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.